IsolatedMYCcytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome-Reference-Cited by-同舟云学术

IsolatedMYCcytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

Published:2015-05-12 Issue:11 Volume:56 Page:3082-3089
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Caponetti Gabriel C.,Dave Bhavana J.,Perry Anamarija M.,Smith Lynette M.,Jain Smrati,Meyer Paul N.,Bast Martin,Bierman Philip J.,Bociek Robert G.,Vose Julie M.,Armitage James O.,Aoun Patricia,Fu Kai,Greiner Timothy C.,Chan Wing C.,Sanger Warren G.,Weisenburger Dennis D.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1034699

Reference37 articles.

1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2. Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

3. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

4. MYC and Aggressive B-cell Lymphomas

5. The Impact of MYC Rearrangements and “Double Hit” Abnormalities in Diffuse Large B-Cell Lymphoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma);American Journal of Clinical Oncology;2019-03

2. Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid Morphology;American Journal of Surgical Pathology;2017-09

3. Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements;Blood;2017-01-19

4. Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation;Journal of Clinical Oncology;2017-01-01

5. Classification of Hodgkin and non-Hodgkin lymphoma;Management of Lymphomas: A Case-Based Approach;2017